(Total Views: 512)
Posted On: 12/20/2019 9:10:06 AM
Post# of 149009
As usual, awesome list trding!
I would suggest to add:
Science Advisors: Dr. Dennis Burger to Science Advisors for his role in GvHD and MS. I am not sure if he is officially a Science Advisor or where that list is available, but he is definitely involved in these two indications. I don't recall the local university he is working with for the MS P2 protocol?
Potential benefits: ZERO Serious Adverse Events in over 850 patients.
HIV: Fast Track Designation, Rolling Review for BLA
Mono: 5 patients on mono for over 4 years; over 100 patients on mono for over 1 year (I don't recall the exact number and dates, but feel this is an important fact to note).
TNBC: Patient 1 CTC reduced to zero in only 8 weeks of treatment.
GvHD: Orphan Drug Designation
Maybe a note about other potential CCR5 indications: MS, COPD, Alzheimer's Disease, Atherosclerosis, Diabetes, HCV, Inflammatory Bowel, Pulmonary Diseases, Rabies, Stroke, TB, etc. with links to the research articles yourself and ohm shared?
I would suggest to add:
Science Advisors: Dr. Dennis Burger to Science Advisors for his role in GvHD and MS. I am not sure if he is officially a Science Advisor or where that list is available, but he is definitely involved in these two indications. I don't recall the local university he is working with for the MS P2 protocol?
Potential benefits: ZERO Serious Adverse Events in over 850 patients.
HIV: Fast Track Designation, Rolling Review for BLA
Mono: 5 patients on mono for over 4 years; over 100 patients on mono for over 1 year (I don't recall the exact number and dates, but feel this is an important fact to note).
TNBC: Patient 1 CTC reduced to zero in only 8 weeks of treatment.
GvHD: Orphan Drug Designation
Maybe a note about other potential CCR5 indications: MS, COPD, Alzheimer's Disease, Atherosclerosis, Diabetes, HCV, Inflammatory Bowel, Pulmonary Diseases, Rabies, Stroke, TB, etc. with links to the research articles yourself and ohm shared?
(1)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼
